Abstract: The use of enhancers to increase the drug molecules penetration into target tissues is an usual technique in drug delivery. In transdermal drug delivery, electric fields are often used to increase the drug transport through the skin. In this paper we study a drug delivery mechanism from a reservoir which is in contact with the skin. We assume that the drug transport in the coupled system is enhanced by a small electric field that induces a convective field. We establish energy estimates for the coupled system and we propose a semi-analytical discrete coupled model that mimics the continuous model. The qualitative behaviour of the system is illustrated.
Introduction
Intelligent drug delivery devices have been developed during the last decades to deliver drugs in a controlled manner at specific locations. Some of these systems use stimuli-responsive polymers (where the drug is entrapped) that are able to respond to the modification of the external environment (like electric fields, pH and temperature). Electric fields are an interesting type of stimulus because they can be precisely controlled, and the drug delivery responses can be predicted.
The use of electric fields as enhancers is popular in transdermal drug delivery where iontophoresis ( [1, 5, 7, 8, 10, 12] ) and electroporation ( [1, 3, 4, 14] ) or a combination of both, are usual procedures. Drug delivery systems for cancer treatment based on this technology were recently developed ( [13] ). In this case, the device based on drug-encapsulated nanoparticles is remotely controlled by an electric field to deliver the biological agent in the cancer target tissue (electrochemotherapy, see [9] ). Each of the above applications involves complex phenomena. For instance, in transdermal drug delivery, enhanced by an electric field, the drug and its solvent vehicle leaves the polymeric matrix, enters the stratum corneum and is transported through the skin to reach the circulatory system. In both media, the transport occurs by passive diffusion, electromigration (migration of ions due to the electric field) and electroosmosis (transport due the solvent movement) ( [7, 11, 12] ).
In an iontophoresis procedure, a small electric field is applied to the coupled system to enhance the drug transport. If the drug molecules are positively charged, then the anode is in contact with the reservoir and the cathode is in the opposite position. The anode will repel the positively charged drug into the skin. If the drug is negatively charged it will be placed under the cathode that will repel it into the skin.The generated electric field induces a convective flux in the system that depends on the drug molecules valence, intensity of the electric field, temperature, electric conductivity of both media and drug diffusion ( [7, 8] ). In this case, the anode is called the active electrode and the cathode the passive electrode.
We are interested in studying transdermal iontophoretic applications consisting of a coupled system having a reservoir containing a charged drug and a tissue, see Figure 1 . In this case, the polymeric reservoir is in contact with the skin which is a multilayered tissue: epidermis (100µm), dermis (2 − 3mm) and subcutaneous tissue. These three layers have different hystological characteristics and functions, however, to simplify the mathematical model, we represent the skin as one layer. The electric field is generated by a potential of low intensity applied during long periods of time. The drug transport occurs by passive diffusion and convection caused by the potential gradient.
The main goal of this paper is the study of a mathematical model that describes the drug transport through the reservoir and the target tissue, under the effect of an electric field. The considered model is a two-layer simplification of the multi-layered model introduced in [6] , in the case of a perfect contact between reservoir and skin. The paper is organized as follows. In Section 2 we present the coupled mathematical model. Solving the coupled problem for the electric field, the convective field is explicitly given and the Laplace-drug equations are replaced by convection-diffusion equations. Energy estimates are obtained in Section 3. Such estimates are used to obtain lower bounds for the released drug. A numerical method that mimics the qualitative behaviour of the continuous model is introduced and studied in Section 4. In Section 5 we present some numerical results illustrating the behaviour of the coupled system in different scenarios. In Section 6 some conclusions are presented.
The Laplace-drug equations
In what follows we assume that the reservoir and the target tissue are isotropic media. This assumption allows the replacement of the 3D physical model, reservoir in contact with the target tissue, by a 1D model. Let [0, 1 ] be the reservoir and ( 1 , 2 ] the target tissue layer. We assume that the left hand side of the reservoir is isolated and the drug molecules that attain the boundary x = 2 are immediately removed. In the domains (0, 1 ) and ( 1 , 2 ) a diffusion process takes place enhanced by the electric field generated by the applied electric potential φ(V ) at x = 0 and x = 2 , respectively, φ 0 and φ 1 . We assume that the polymeric matrix of the reservoir and the target tissue have different electric conductivities σ r and σ s (S/m), respectively. We also assume that the diffusion coefficients of the drug in both media are represented, respectively, by D r and D s (m 2 /s). The drug transport in the polymeric matrix occurs by passive diffusion and convection induced by the electric field E = −∇φ. Let J r be the drug mass flux. By the Nernst-Planck equation we have
where c r denotes the drug concentration (g/m 3 ) in the polymeric matrix and v r (m/s) stands for the mean velocity of the solvent vehicle in the reservoir. Let J s represent the drug mass flux in the skin. By the Nernst-Planck equation we have
where c r denotes the drug concentration in the target tissue. The convective velocity v sol , caused by the electric field, represents the average velocity of the solvent vehicle.
The convective velocities v k , k = r, s, are given by the Nernst-Einstein equation
where z denotes the valence of the drug molecules, R the Faraday constant (9.6485 × 10 4 Coulomb/mol), T i the temperature (K) in the medium i, and R de gas constant (8.31446J/(Kmol)).
We assume that the electric field is generated by applying low potentials during long periods of time. In these circumstances, the potential is described by the Laplace equation. As both media present different conductivity properties, two Laplace equations should be considered coupled with the convection-diffusion equations for the drug transport. From the previous considerations, the electric potentials in the reservoir, φ r , and the skin, φ s , are described by the two equations
and
coupled with the transition condition    φ r ( 1 ) = φ s ( 1 ) (continuity of the potential) σ r ∇φ r ( 1 ) = σ s ∇φ s ( 1 ) (continuity of the electric field).
We note that condition φ s ( 2 ) = φ 1 , in (4), represents an approximation of the real experimental condition. The potential φ s is not applied in 2 -the interface between the skin and the blood system -but at the passive electrode.
The time-space drug evolution is described by the mass conservation law
coupled with the Nernst-Planck equations (1)- (2). Then, for c k , k = r, s, we obtain
The boundary condition in (6) means that the system is insulated while the boundary condition in (7) states that the drug is immediately removed by the blood stream.
System (6)- (7) is complemented with the interface conditions
and the initial condition
Condition (9) means that there is initially a homogeneous drug distribution in the reservoir and that the target tissue is empty.
The drug delivery
Solving the potential problems (3), (4) and (5) we easily obtain
where δφ = φ 1 − φ 0 is the potential difference. From (10) and (2) we deduce the convective velocities
We introduce now the weak formulation of the initial boundary value coupled problem (6), (7), (8) and (9). To do that we define the following space
where (·, ·) denotes the usual inner product in L 2 (0, 2 ), and
Then the drug distribution is defined by
In (12) , D and v are defined by
To study the stability of the weak problem we recall the following FriedrichsPoincaré inequality
An energy estimate for c(t) was established in [6] , which we recall in Theorem 1.
) is a solution of (12), (13) then
From Theorem 1, the stability (as well as uniqueness of solution) of the IBVP (12), (13) can be concluded.
The upper bound (15) can be used to study the qualitative behaviour of the drug mass inside of the coupled system and the absorbed drug. Let
be the total drug mass in the coupled system, where A represents the area of a square cross section and √ A is the distance between the passive and active electrodes, see Figure 2 . Figure 2 . Simplified representation of the problem (A e represents the active electrode and P e the passive one).
As M (t) ≤ 2 A c(t) , we obtain from Theorem 1 an upper bound for this mass. 
then lim t→∞ M (t) = 0 exponentially.
Let P e , the Péclet number, be defined by Condition (17) means that if the Péclet number is less than √ 2 then we can easily compute the time level t * such that the drug mass in the coupled system is less than a positive limit L. In fact, from (16), t * satisfies
As A √ 2 c(0) represents the initial mass in the system, we always have L ≤ A √ 2 c(0) and consequently, estimate (19) is physically sound. Let M abs (t) be the absorbed mass at time t ∈ R + ,
It follows from (16) that
To obtain a second estimate for M (t), we need to improve estimate (15). Taking in (12) 
From (21) we deduce
Assuming (17) we obtain
and finally
From the previous considerations we conclude that under condition (17), we have
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As we have P
we conclude that the upper bound of (16) for the drug mass in the reservoirtarget tissue is greater or equal than the upper bound in (23). Furthermore, in this case, the instant t * such that M (t) < L corresponding to (19) is given by
where the lower bound in (24) is smaller than the lower bound in (19). From (24) we obtain
(25) We finally observe that estimates (20) and (25) can be used to study the dependence of the lower limits for absorbed mass on the parameters that determine the iontophoresis.
A discrete model
In this section we present a finite difference method that presents the same qualitative behaviour of the continuous model. We fix a mesh size h in [0, 2 ] and we define the following grid I h = {x i , i = 0, . . . , N }:
. By I * h we denote the grid I h ∪ {x −1 }. By D −x , D c and D 2 we denote the backward, first order centered and second order centered finite difference operators, respectively. By M 4 and M 2 we represent the average operators
respectively. We consider that D 2 v h (x M −1 ) is based on a nonuniform grid and defined using the grid points x M −2 , x M −1 and
is defined using the nonequally spaced grid points x M −2 and x M −1/2 . We also introduce the boundary operator D η
Let c h (t) be a grid function defined in the grid points I * h ∪ {x M −1/2 } that satisfies the following system of differential equations
where v k = v r , if i ≤ M −1, and v k = v s otherwise, coupled with the following algebraic conditions
We assume that at the initial time we have
The boundary conditions (27) are the discretizations of the boundary conditions of the differential problem. Moreover, the interface condition (28) is a discrete version of (8) . The semi-discete problem (26)-(29) can be rewritten in the following equivalent form
To study the qualitative behaviour of the semidiscrete approximation c h (t) defined by (30) we introduce now the convenient functional environment following [2] .
We introduce the following discrete L 2 (0, 2 ) inner product (·, ·) h for grid functions defined in I h and null on x N ,
By · h we denote the norm induced by this inner product. For grid functions defined in I h ∪ {x M −1/2 } we use the following notations
We remark that (·, ·) h and (·, ·) h,+ satisfy
for all grid functions u h , v h defined in I * h ∪ {x M −1/2 } where u h and v h satisfy (27), (28) for v r = v s = 0. Condition (32) mimics the correspondent continuous relation and it is the basic compatibility requirement for (·, ·) h and (·, ·) h,+ . We observe that existence of the transition point where (28) holds increases the complexity of the analysis and the need of auxiliary results that will have an important role in what follows.
The following discrete Poincaré inequalities have an important role in what follows.
Theorem 2. For grid functions v h defined in I h ∪ {x M −1/2 } and null on the boundary point x N we have
Proof : To simplify the presentation we denote by h i , i = 1, . . . , N + 1, the distance between two consecutive points of the grid I h ∪ {x M −1/2 }. As we have
that leads to (33). The proof of inequality (34) follows the same steps.
If u h is defined in I h ∪ {x M −1/2 , null at x = x N and satisfies
with
provided that h satisfies the following condition
It can be showed that L h is nonsingular for a certain class of coupled problems.
Theorem 3. If P e < √ 2, (38) then the finite difference operator L h is nonsingular in the space
Proof : Using summation by parts we establish
We have successively
From (39), (40) and using (33) we get
that concludes the proof.
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We remark that the previous bound (41) leads to
We recall that the logarithmic norm of the linear operator L h (or its matrix representation) µ[L h ] induced by the inner product (·, ·) h is given by
As c h (t) satisfies (26)- (28), it follows
As we have
we obtain the following result:
Theorem 4. Let c h (t) be a grid function defined in I * h ∪{x M −1/2 } that satisfies (26)-(29). If (37) and (38) hold then
Theorem 4 allow us to conclude the stability of the initial boundary value problem (26)-(29). Let
be the discrete drug mass in the coupled system. Theorem 4 can be used to obtain an estimate for M h (t). In fact, under condition (38) we have
. We also get a lower estimate for the absorbed mass M abs (t)
Let us consider in the integration in time of the semi-discrete problem (26)-(29) the implicit-Euler method. To do that we fix a time interval [0, T ] where we introduce a time grid {t n , n = 0, . . . , N ∆t } where t n −t n−1 = ∆t, n = 1, . . . , N ∆t , and N ∆t ∆t = T. Let c n h , n = 0, . . . , N ∆t , be defined by c 
Under condition (38) we establish in the next result that the fully discrete scheme (45)- (48) is unconditionally stable. 
where
Also, if
is nonnegative or positive such that B∆t < 1, then the finite difference scheme (45)-(48) satisfies
Proof : From (45)- (48) we establish
(1) P e < 1: Taking into account inequality (34) we get
where B is defined by (51). If B < 0, then an estimate like (49) holds, replacing C for |B|. Otherwise, if B > 0 is such that B∆t < 1 then from (60) we get
Finally, inequality (52) easily follows from (61).
Theorem 5 means that the implicit method (45)- (48) is unconditionally stable when P e < 1 or when B < 0. Otherwise, it is conditionally stable.
Numerical results
In this section we illustrate the behaviour in different scenarios of the drug concentration in the reservoir and target tissue as well as the released drug. We consider 1 = 10 −3 , 2 = 2.5 × 10 −3 (m), for a reservoir with 1(mm) of thickness and a target tissue of 1.5(mm) of thickness and A = 1.
We analyze the dependence on the concentration with the applied potential and the reservoir and target tissue conductivities. The coupled system's parameters (see [3] The scenarios are defined considering the valence z of the diffusion drug equal to −1. The numerical results were obtained using the fully implicit scheme (45)-(48). In Figure 3 we present the concentration profiles for different values of δφ, δφ = 0, 0.02, 0.5, 2. As δφ increases, the convective rate of transport also increases and consequently, less drug concentration remains in the reservoir and in the target tissue. This behaviour can be observed from the plot of the absorbed mass in Figure 3 . We also illustrate the influence of the electric conductivity coefficients. In Figure 4 we plot the drug concentrations and the released mass for σ s = 0.015. We observe that a lower electric conductivity in the reservoir can lead to an increase of the released mass. These results were obtained for δφ = 0.5. Figures 3 and 4 (right) suggest that the reservoir's conductivity has a large influence, on the total amount of released drug, than the potential δφ. A number of simulations that has been carried on Table 1 which clarifies the dependence of the total mass of absorbed over six hours, on the conductivity σ r and the potential δφ. In these tables, M 0 (6) represents the total mass absorbed when δφ = 0. The influence of σ r explains why polymeric conductivity is a major concern for manufacturers.
We finally present how estimate (44) can be useful. In Figure 5 we plot the real absorbed mass, as well as lower bound (44), which can be used to design protocols for drug delivery in this context. The parameters chosen for this particular simulation are D s = D r = 10 −8 , δφ = 0.02 and σ r = 0.15. The remaining parameters are taken as in the previous simulations.
Conclusion
In this paper the mathematical model that describes the drug evolution in the coupled reservoir-target tissue is studied when the drug transport is enhanced by an applied electric field. We assume that the applied potential is stationary and is described by a coupled system that admits an explicit solution. As the electric field generates a convective field, the drug transport occurs by passive diffusion, convection defined by the electric field and by the solute transport when the charge of the drug is negative. Table 1 . Behaviour of the total mass absorbed for six hours, M δφ (6) . The convection-diffusion drug system was studied and its stability was concluded under different assumptions on the parameters of the model. The energy estimates were used to obtain estimates for the drug in the coupled system and for the released drug. Such estimates can be used to design iontophoretic systems with a prescribed behaviour.
A numerical method that mimics the continuous model was proposed. The discrete interface conditions induces difficulties in the stability analysis. To avoid such problems a convenient L 2 discrete norm and seminorm were introduced and a discrete Poincaré inequality was proved. These ingredients were crucial to establish discrete energy estimates for an implicit method. The qualitative behaviour of the numerical solutions was explored.
